SESN2 and breast carcinoma: We performed SRB assay and clonogenic survival assay to investigate the effect of SESN2 knockdown on the cytotoxicity of BA treatment in the three breast cancer cell lines, MDA-MB-231, MCF-7 and HS578T, under normoxic and hypoxic conditions.